Prelude Therapeutics
PRLD
PRLD
60 hedge funds and large institutions have $1.41B invested in Prelude Therapeutics in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
9.44% less ownership
Funds ownership: 79.29% → 69.85% (-9.4%)
43% less capital invested
Capital invested by funds: $2.47B → $1.41B (-$1.06B)
Holders
60
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$88.5M | |
| 2 | +$31.7M | |
| 3 | +$8.99M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.06M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$5.5M |
Top Sellers
| 1 | -$241M | |
| 2 | -$7.95M | |
| 3 | -$5.35M | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$3.58M |
| 5 |
Squarepoint
New York
|
-$1.48M |